A proven, experienced CRO and service-provider, Alcyomics has developed unique non-animal non-artificial human based in vitro assays that transform drug development by enabling early and accurate identification of safe and efficacious compounds. As a service provider Alcyomics aspires to take the lead in providing unique screening services enabling more cost-effective commercialization of products and or drugs offering a reliable alternative to animal testing for safety and potency assessment of novel compounds. They use their patented technology, Skimune®, a non-artificial human skin explant test to accurately predict adverse immune reactions.
